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The recent article published covering “The role of autonomic dysfunction in predicting 1-
year mortality after liver transplantation” (1) provides some useful insight into post-
transplantation survival. However, it seems to us that the data lend themselves to a 
different interpretation, possibly pointing to a new application of heart rate variability 
analysis in patients awaiting liver transplantation.  
 
Based on the data presented in the study, the combination of the MELD score and measures 
of heart rate dynamics improves the accuracy in predicting mortality 1-year post-
transplantation. However, this may have been misinterpreted as a novel index for organ 
allocation in patients awaiting liver transplantation. In contrast, we suggest that the 
measures of heart rate dynamics should instead be used as a separate co-morbidity factor 
to assess suitability for transplantation. This is because, as the study results show, heart rate 
dynamics behave differently to how renal and liver function behave following 
transplantation (Table 1, reference (1)). Measures of heart rate dynamics are unchanged, 
while liver and renal function improve after transplantation (2). Although both MELD score 
and measures of heart rate dynamics predict mortality post transplantation, it is important 
to note that heart rate complexity and deceleration capacity are stagnant following 
transplantation. This suggests that there is no significant improvement in cardiac autonomic 
function 1-year post transplantation. Previous studies confirm this finding showing that 
aspects of autonomic dysfunction 1-year post-transplantation do not improve in patients 
with cirrhosis (3). Thus, combining heart rate dynamics with MELD score for organ allocation 
would be equivalent to combining MELD score with a co-morbidity factor (e.g. severe 
cardiopulmonary disease or extrahepatic malignancy). Although the integrated score may 
predict post transplantation mortality better than MELD score alone, it will certainly not 
help identifying the most suitable candidates for liver transplantation. 
 
Cardiac dysfunction also plays an increasingly important role in post-transplantation 
mortality (4). Perhaps the predictive ability of heart rate dynamics observed in the study by 
Chan et al. relates  to the fact that patients were categorised into sub-groups  with varying 
cardiac autonomic function, measured by a reduction in heart rate complexity (1). Thus, this 
heart rate complexity index could be used as a pre-transplant screening tool to identify 
individuals at high risk of a post-transplant death, rather than in combination with MELD for 
organ allocation purposes.  
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